How much does a 510k submission cost with FDA fees in 2024?

## How to Budget for FDA 510(k) User Fees in 2024: A Guide to the Small Business Determination (SBD) Process When planning a 510(k) submission for a new medical device, one of the most predictable yet critical budget items is the FDA user fee. Mandated by the Medical Device User Fee Amendments (MDUFA), this fee must be paid for the FDA to accept a submission for review. For the fiscal year 2024, the FDA has established a standard fee for 510(k) submissions, but it also offers a substantially reduced fee for organizations that qualify as a "small business." Securing this lower fee is not automatic; it requires a proactive application process known as a Small Business Determination (SBD). This process has strict documentation requirements and a specific timeline that must be managed carefully. A company cannot simply claim small business status on its 510(k) application; it must have an approved SBD from the FDA *before* submitting its 510(k). This guide provides a detailed breakdown of the SBD application process, eligibility criteria, and strategic considerations to help sponsors budget accurately and avoid common pitfalls. For the most current fee schedules, sponsors must always consult the official FDA website, as these figures are updated annually. This article will focus on the *process* of qualifying for the reduced fee, not the specific dollar amounts. ### Key Points * **SBD Approval is a Prerequisite:** A company must apply for and receive an approved Small Business Determination (SBD) from the FDA *before* submitting its 510(k). You cannot pay the reduced fee without a valid SBD decision number. * **Strict Financial Criteria:** Eligibility is based on the gross receipts or sales of the applicant company and all of its affiliates (parent, subsidiary, or sister companies). The FDA has a specific financial threshold, which is updated periodically. * **Timeline is Critical:** The FDA may take up to 60 calendar days to review an SBD application. Sponsors should submit their SBD application at least two months before their planned 510(k) submission to avoid delays. * **Documentation Must Be Complete:** The application requires a specific FDA form and complete federal tax returns for all entities, including parent companies and affiliates. Incomplete applications are a common cause of delays or denial. * **Annual Renewal is Required:** SBD status is granted for the federal government's fiscal year (October 1 to September 30). If a company plans submissions in a new fiscal year, it must reapply. * **Official Source is Paramount:** MDUFA user fees change every year. Always refer to the FDA's official website for the current fee schedule, application forms, and eligibility thresholds. ### Understanding FDA 510(k) User Fees Under the authority granted by MDUFA, the FDA collects user fees from medical device companies to help fund the review process for device submissions. This program is intended to provide the FDA with resources to conduct reviews in a timely and predictable manner. For 510(k) premarket notifications, two fee rates exist: 1. **Standard Fee:** The full fee applicable to most submissions. 2. **Small Business Fee:** A significantly reduced fee for companies that meet the FDA's definition of a small business. Obtaining the small business fee can result in substantial cost savings, making it a critical strategic step for startups and smaller companies. However, incorrectly assuming qualification can lead to significant budgetary shortfalls and submission delays if the full fee is required unexpectedly. Therefore, understanding and correctly navigating the SBD application process is essential for financial planning. For current FDA user fee information, sponsors should consult the FDA website at `https://www.fda.gov/industry/fda-user-fees`. ### The Small Business Determination (SBD) Program: A Step-by-Step Guide The SBD program is administered by the FDA's Center for Devices and Radiological Health (CDRH). The process is straightforward but requires careful attention to detail and timelines. #### Step 1: Determine Eligibility Before beginning the application, a sponsor must confirm it meets the FDA's financial criteria. The primary requirement relates to the company's "gross receipts or sales." * **Calculate Gross Receipts or Sales:** This figure must be calculated from the most recently completed federal tax year. * **Include All Affiliates:** This is a critical and often overlooked step. The calculation must include the gross receipts or sales of the applicant company PLUS all of its domestic and foreign affiliates. Affiliates include: * Parent companies * Subsidiary companies * Any other businesses under common ownership or control A company with low internal revenue may be ineligible if it is owned by a larger parent corporation. Sponsors should work closely with their finance or accounting teams to ensure this calculation is performed accurately according to FDA guidance. #### Step 2: Assemble the Required Documentation A complete SBD application package is essential for a timely review. The following documents are typically required: 1. **SBD Application Form (Form FDA 3602):** This is the official request form. Sponsors must ensure they are using the most current version available on the FDA's website. The form requires information about the applicant company and a list of all affiliates. 2. **Federal Income Tax Returns:** A complete copy of the most recent U.S. federal income tax return for the applicant company and every affiliate (including parent and subsidiary companies). If an affiliate is a foreign entity and does not file a U.S. tax return, other official government documentation of its annual sales may be accepted. 3. **Organizational Chart:** A chart illustrating the ownership structure and relationship between the applicant and all its affiliates. This helps the FDA reviewer verify that all relevant entities have been included in the application. 4. **Cover Letter:** A brief, formal cover letter on company letterhead that clearly states the purpose of the submission (e.g., "Request for Small Business Determination"). #### Step 3: Submit the SBD Application Once the package is complete, it should be submitted to the FDA's SBD Program. The FDA typically accepts these applications electronically via a dedicated email address found on the agency's MDUFA user fee webpages. Submitting early is paramount. A good rule of thumb is to submit the SBD application **60 to 90 days before** the planned 510(k) submission date. #### Step 4: Await FDA Review and Decision The FDA states that it will review a complete SBD application within 60 calendar days. Upon approval, the FDA will issue a letter containing a unique **Small Business Decision Number**. This number is proof of qualification and is valid for the current fiscal year. This decision number **must be included on the 510(k) User Fee Cover Sheet (Form FDA 3601)** that accompanies the 510(k) submission. Without this number, the FDA will not accept payment of the reduced fee. ### Common Pitfalls and How to Avoid Them Navigating the SBD process successfully requires avoiding several common mistakes that can delay or invalidate a 510(k) submission. * **Pitfall 1: Applying Too Late.** The most common error is underestimating the 60-day review timeline. If a company submits its SBD application one week before its 510(k), it will not receive a decision in time. The 510(k) submission will be placed on hold until the full fee is paid or SBD approval is granted, delaying the start of the review clock. * **Solution:** Treat the SBD application as a critical-path activity and submit it at least two months in advance of the target 510(k) submission date. * **Pitfall 2: Miscalculating Gross Receipts.** Forgetting to include revenue from a parent company or a foreign affiliate is a frequent cause for denial. The FDA cross-references tax documents and organizational charts to verify these relationships. * **Solution:** Work with financial and legal experts to map the full corporate structure and consolidate all required financial data before applying. * **Pitfall 3: Submitting Incomplete Documentation.** Missing tax forms for an affiliate, providing an outdated application form, or submitting an unclear organizational chart will result in the FDA sending a request for additional information, which resets the review timeline. * **Solution:** Create an internal checklist based on the FDA's requirements and have a colleague double-check the package for completeness before submission. * **Pitfall 4: Incorrectly Budgeting.** A company that budgets for the small business fee without having SBD approval in hand takes a significant financial risk. If the application is denied, the company must suddenly find the funds for the full standard fee, which can be a major unplanned expense. * **Solution:** For conservative budgeting, plan for the standard fee and treat the small business fee as a potential cost savings only after SBD approval is confirmed. ### Strategic Considerations and the Role of Q-Submission Integrating the SBD application into the broader regulatory strategy is a mark of a well-prepared organization. The timeline for regulatory activities provides a useful framework for administrative tasks like the SBD application. For example, many sponsors engage with the FDA through the Q-Submission program to get feedback on testing plans or regulatory pathways several months before their final 510(k) submission. The period during which the team is preparing a Q-Submission or awaiting FDA feedback is an ideal time to also prepare and submit the SBD application. This ensures that the administrative prerequisite (SBD approval) is secured in parallel with the technical and scientific preparations, preventing it from becoming a last-minute bottleneck. ### Key FDA References - FDA Guidance: general 510(k) Program guidance on evaluating substantial equivalence. - FDA Guidance: Q-Submission Program – process for requesting feedback and meetings for medical device submissions. - 21 CFR Part 807, Subpart E – Premarket Notification Procedures (overall framework for 510(k) submissions). ## How tools like Cruxi can help Managing the numerous documents, timelines, and requirements for a 510(k) submission can be complex. Regulatory intelligence platforms can help teams organize their submission content, track key deadlines for prerequisites like the SBD application, and maintain a structured library of all necessary documentation. By centralizing information and providing frameworks for submission building, these tools can help ensure that administrative requirements are not overlooked in the push to finalize technical and clinical data. *** *This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program.* --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*